Translational medicine is turning futuristic ideas into reality, and liquid biopsies are a perfect example. Instead of invasive tissue biopsies, doctors can now analyze circulating tumor DNA (ctDNA) from a simple blood draw to detect cancer early, track treatment response, and spot relapse months before imaging scans can.
Trials have shown that liquid biopsies detect mutations in lung, breast, and colorectal cancers with remarkable accuracy. As costs drop, this approach could make routine cancer screening as simple as a blood test at your annual checkup.
Informative and advantageous. Difficulty in taking biopsies of various internal organs can be averted.Also, reduction in time for diagnosis will also hasten treatment.
Liquid biopsies are a remarkable step forward, offering hope for earlier detection and more precise cancer care. It is inspiring to see science moving toward simple blood tests that could save countless lives.